Abstract
Most of the small number of cases of poliomyelitis which occur in countries where Sabin's attenuated poliovirus vaccines are used are temporally associated with administration of vaccine and involve polioviruses of types 2 and 3 (ref. 1). Recent studies have provided convincing evidence that the Sabin type 2 and 3 viruses themselves may revert to a neurovirulent phenotype on passage in man2–6. We report here that a point mutation in the 5′ noncoding region of the genome of the poliovirus type 3 vaccine consistently reverts to wild type in strains isolated from cases of vaccine-associated poliomyelitis. Virus with this change is rapidly selected on passage through the human gastrointestinal tract. The change is associated with a demonstrable increase in the neurovirulence of the virus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Assaad, F. & Cockburn, W. C. Bull Wld Hlth Org. 60, 231–242 (1982).
Minor, P. D. J. Virol. 34, 73–84 (1980).
Minor, P. D. J. gen. Virol. 59, 307–317 (1982).
Cann, A. J. et al. Nucleic Acids Res. 12, 7787–7792 (1984).
Cossart, Y. E. Br. med. J. 1, 162–163 (1977).
Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H. & Obijeski, J. F. J. gen. Virol. 56, 337–347 (1981).
Stanway, G. et al. Proc. natn. Acad. Sci. U.S.A. 81, 1539–1543 (1984).
Stanway, G. et al. Eur. J. Biochem. 135, 529–533 (1983).
WHO Collaborative Study. J. biol. Standard. 9, 163–184 (1981).
Evans, D. M. A., Minor, P. D., Schild, G. C. & Almond, J. W. Nature 304, 459–462 (1983).
Toyoda, H. et al. J. molec. Biol. 174, 561–585 (1984).
Magrath, D. I., Boulger, L. R. & Hartley, E. G. 10th Eur. Symp. Poliomyelitis, 334–345 (EAP, 1964).
Sanger, F., Nicklen, S. & Coulson, A. R. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Tech. Rep. Ser. Wld Hlth Org. 687, 130 (1983).
Tech. Rep. Ser. Wld Hlth Org. 687, 134 (1983).
Nomoto, A. et al. Proc. natn. Acad. Sci. U.S.A. 79, 5793–5797 (1982).
Stanway, G., Hughes, P. J., Mountford, R. C., Minor, P. D. & Almond, J. W. Nucleic Acids Res. 12, 7859–7875 (1984).
Jacobson, A. B., Good, L., Simonetti, J. & Zuker, M. Nucleic Acids Res. 12, 45–52 (1984).
Shapiro, B. A., Maizel, J. V., Lipkin, L. E., Currey, K. & Whitney, C. Nucleic Acids Res. 12, 75–88 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Evans, D., Dunn, G., Minor, P. et al. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314, 548–550 (1985). https://doi.org/10.1038/314548a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/314548a0
This article is cited by
-
Poliomyelitis is a current challenge: long-term sequelae and circulating vaccine-derived poliovirus
GeroScience (2023)
-
Enterovirus A71 and coxsackievirus A16 show different replication kinetics in human neuronal and non-neuronal cell lines
Archives of Virology (2017)
-
Exchanges of genomic domains between poliovirus and other cocirculating species C enteroviruses reveal a high degree of plasticity
Scientific Reports (2016)
-
Complete genome sequencing and analysis of six enterovirus 71 strains with different clinical phenotypes
Virology Journal (2013)
-
Role of RNA Structure Motifs in IRES-Dependent Translation Initiation of the Coxsackievirus B3: New Insights for Developing Live-Attenuated Strains for Vaccines and Gene Therapy
Molecular Biotechnology (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
